51 related articles for article (PubMed ID: 1546918)
1. [Inappropriate use of third generation cephalosporins in primary care].
Garrido Díez A; de La Cal López M; de Aramburu Pataut J; Velasco Merino V; Lamas López M; Montes Martínez I
Aten Primaria; 2001 May; 27(8):581-2. PubMed ID: 11412549
[No Abstract] [Full Text] [Related]
2. Sustained Reduction in Third-generation Cephalosporin Usage in Adult Inpatients Following Introduction of an Antimicrobial Stewardship Program in a Large, Urban Hospital in Malawi.
Lester R; Haigh K; Wood A; MacPherson EE; Maheswaran H; Bogue P; Hanger S; Kalizang'oma A; Srirathan V; Kulapani D; Mallewa J; Nyirenda M; Jewell CP; Heyderman R; Gordon M; Lalloo DG; Tolhurst R; Feasey NA
Clin Infect Dis; 2020 Dec; 71(9):e478-e486. PubMed ID: 32060523
[TBL] [Abstract][Full Text] [Related]
3. Strategies to enhance rational use of antibiotics in hospital: a guideline by the German Society for Infectious Diseases.
de With K; Allerberger F; Amann S; Apfalter P; Brodt HR; Eckmanns T; Fellhauer M; Geiss HK; Janata O; Krause R; Lemmen S; Meyer E; Mittermayer H; Porsche U; Presterl E; Reuter S; Sinha B; Strauß R; Wechsler-Fördös A; Wenisch C; Kern WV
Infection; 2016 Jun; 44(3):395-439. PubMed ID: 27066980
[TBL] [Abstract][Full Text] [Related]
4. Ciprofloxacin or imipenem use correlates with resistance in Pseudomonas aeruginosa.
Zhanel GG; Nicolle LE; Gin AS; Karlowsky J; Kabani A; Hoban DJ
Can J Infect Dis; 1998 Nov; 9(6):382-6. PubMed ID: 22346558
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial resistance among Gram-negative bacilli causing infections in intensive care unit patients in the United States between 1993 and 2004.
Lockhart SR; Abramson MA; Beekmann SE; Gallagher G; Riedel S; Diekema DJ; Quinn JP; Doern GV
J Clin Microbiol; 2007 Oct; 45(10):3352-9. PubMed ID: 17715376
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial stewardship programs in health care systems.
MacDougall C; Polk RE
Clin Microbiol Rev; 2005 Oct; 18(4):638-56. PubMed ID: 16223951
[TBL] [Abstract][Full Text] [Related]
7. Using cost of infection as a tool to demonstrate a difference in prophylactic antibiotic efficacy: a prospective randomized comparison of the pharmacoeconomic effectiveness of ceftriaxone and cefotaxime prophylaxis in abdominal surgery.
Woodfield JC; Van Rij AM; Pettigrew RA; van der Linden A; Bolt D
World J Surg; 2005 Jan; 29(1):18-24. PubMed ID: 15599747
[TBL] [Abstract][Full Text] [Related]
8. Place of parenteral cephalosporins in the ambulatory setting: clinical evidence.
Nathwani D
Drugs; 2000; 59 Suppl 3():37-46; discussion 47-9. PubMed ID: 10845412
[TBL] [Abstract][Full Text] [Related]
9. Ceftriaxone. A pharmacoeconomic evaluation of its use in the treatment of serious infections.
Davis R; Bryson HM
Pharmacoeconomics; 1994 Sep; 6(3):249-69. PubMed ID: 10155268
[TBL] [Abstract][Full Text] [Related]
10. The formulary decision-making process in a US academic medical centre.
Nash DB; Catalano ML; Wordell CJ
Pharmacoeconomics; 1993 Jan; 3(1):22-35. PubMed ID: 10146985
[TBL] [Abstract][Full Text] [Related]
11. The impact of blood culture reporting and clinical liaison on the empiric treatment of bacteraemia.
Cunney RJ; McNamara EB; Alansari N; Loo B; Smyth EG
J Clin Pathol; 1997 Dec; 50(12):1010-2. PubMed ID: 9516883
[TBL] [Abstract][Full Text] [Related]
12. Enterobacter spp.: pathogens poised to flourish at the turn of the century.
Sanders WE; Sanders CC
Clin Microbiol Rev; 1997 Apr; 10(2):220-41. PubMed ID: 9105752
[TBL] [Abstract][Full Text] [Related]
13. Drug utilisation review (DUR) of the third generation cephalosporins. Focus on ceftriaxone, ceftazidime and cefotaxime.
Adu A; Armour CL
Drugs; 1995 Sep; 50(3):423-39. PubMed ID: 8521766
[TBL] [Abstract][Full Text] [Related]
14. A randomized trial of the effects of pharmacist intervention on the cost of antiemetic therapy with ondansetron.
Dranitsaris G; Warr D; Puodziunas A
Support Care Cancer; 1995 May; 3(3):183-9. PubMed ID: 7655779
[TBL] [Abstract][Full Text] [Related]
15. Practical strategies for the appropriate use of antimicrobials.
Guglielmo BJ
Pharm World Sci; 1995 Jul; 17(4):96-102. PubMed ID: 7581222
[TBL] [Abstract][Full Text] [Related]
16. Impact of voluntary vs enforced compliance of third-generation cephalosporin use in a teaching hospital.
Bamberger DM; Dahl SL
Arch Intern Med; 1992 Mar; 152(3):554-7. PubMed ID: 1546918
[TBL] [Abstract][Full Text] [Related]
17. Relationship between ceftriaxone use and resistance to third-generation cephalosporins among clinical strains of Enterobacter cloacae.
Muller A; Lopez-Lozano JM; Bertrand X; Talon D
J Antimicrob Chemother; 2004 Jul; 54(1):173-7. PubMed ID: 15150164
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic use in neonatal sepsis.
Yurdakök M
Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
